TLSI (STOCKS)
TriSalus Life Sciences, Inc. Common Stock
$5.630000
-0.080000 (-1.40%)
Prev close: $5.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Mary T. Szela
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $416.73M
- Employees
- 110
- P/E (TTM)
- -4.41
- P/B (TTM)
- 53.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.16 | $-0.16 | -0.0019 | -1.20% |
|
Mar 2026 (Q1)
|
$0.03 | $-0.16 | +0.1891 | +118.86% |
|
Dec 2025 (Q4)
|
$-0.21 | $-0.13 | -0.0757 | -56.37% |
|
Sep 2025 (Q3)
|
$-0.25 | $-0.15 | -0.0985 | -65.02% |
Financial Statements
| Revenues | $45.08M |
| Benefits Costs and Expenses | $73.28M |
| Cost Of Revenue | $6.41M |
| Costs And Expenses | $73.28M |
| Gross Profit | $38.67M |
| Operating Expenses | $69.18M |
| Depreciation and Amortization | $560.00K |
| Research and Development | $14.10M |
| Other Operating Expenses | $54.68M |
| Operating Income/Loss | -$30.51M |
| Income/Loss From Continuing Operations After Tax | -$28.21M |
| Income/Loss From Continuing Operations Before Tax | -$28.20M |
| Income Tax Expense/Benefit | $13.00K |
| Net Income/Loss | -$28.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$28.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$58.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.46M |
| Preferred Stock Dividends And Other Adjustments | $30.46M |
| Basic Earnings Per Share | -$1.22 |
| Diluted Earnings Per Share | -$1.22 |
| Basic Average Shares | 101,034,117 |
| Diluted Average Shares | 101,034,117 |
| Assets | $62.45M |
| Current Assets | $59.74M |
| Inventory | $4.21M |
| Prepaid Expenses | $2.79M |
| Other Current Assets | $52.75M |
| Noncurrent Assets | $2.70M |
| Liabilities | $55.90M |
| Current Liabilities | $11.17M |
| Noncurrent Liabilities | $44.73M |
| Equity | $6.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.55M |
| Liabilities And Equity | $62.45M |
| Net Cash Flow From Operating Activities | -$22.80M |
| Net Cash Flow From Operating Activities, Continuing | -$22.80M |
| Net Cash Flow From Investing Activities | -$440.00K |
| Net Cash Flow From Investing Activities, Continuing | -$440.00K |
| Net Cash Flow From Financing Activities | $42.69M |
| Net Cash Flow From Financing Activities, Continuing | $42.69M |
| Net Cash Flow | $19.45M |
| Net Cash Flow, Continuing | $19.45M |
| Comprehensive Income/Loss | -$28.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$28.21M |
| Other Comprehensive Income/Loss | $0.00 |